Cross-species analysis of SHH medulloblastoma models reveals significant inhibitory effects of trametinib on tumor progression
Abstract Sonic Hedgehog (SHH) medulloblastomas (MBs) exhibit an intermediate prognosis and extensive intertumoral heterogeneity. While SHH pathway antagonists are effective in post-pubertal patients, younger patients exhibit significant side effects, and tumors that harbor mutations in downstream SH...
Main Authors: | Stephanie Borlase, Alexandria DeCarlo, Ludivine Coudière-Morrison, Lisa Liang, Christopher J. Porter, Vijay Ramaswamy, Tamra E. Werbowetski-Ogilvie |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2023-09-01
|
Series: | Cell Death Discovery |
Online Access: | https://doi.org/10.1038/s41420-023-01646-0 |
Similar Items
-
Combined MEK and JAK/STAT3 pathway inhibition effectively decreases SHH medulloblastoma tumor progression
by: Jamie Zagozewski, et al.
Published: (2022-07-01) -
Characterization of a novel OTX2‐driven stem cell program in Group 3 and Group 4 medulloblastoma
by: Margaret Stromecki, et al.
Published: (2018-04-01) -
Deconstruction of Medulloblastoma Cellular Heterogeneity Reveals Differences between the Most Highly Invasive and Self-Renewing Phenotypes
by: Ludivine Coudière Morrison, et al.
Published: (2013-04-01) -
The transcriptional landscape of Shh medulloblastoma
by: Patryk Skowron, et al.
Published: (2021-03-01) -
Developmental basis of SHH medulloblastoma heterogeneity
by: Maxwell P. Gold, et al.
Published: (2024-01-01)